PCM
ANGO icon

Penn Capital Management’s AngioDynamics ANGO Stock Holding History

Penn Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-94,087
Closed -$1.51M – 190
2019
Q4 		$1.51M Sell
94,087
-65,826
-41% -$1.01M 0.16% 183
2019
Q3 		$2.95M Buy
159,913
+31,533
+25% +$617K 0.31% 124
2019
Q2 		$2.53M Buy
128,380
+16
+0% +$326 0.25% 132
2019
Q1 		$2.93M Buy
128,364
+26,185
+26% +$568K 0.28% 119
2018
Q4 		$2.06M Buy
+102,179
New +$2.11M 0.2% 136

Other funds holding ANGO

Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Penn Capital Management's ANGO Position: Q1 2020 in Review

Penn Capital Management sold out of AngioDynamics (ANGO) in Q1 2020, closing a stake of 94,087 shares — an estimated $1.51M sold.

Penn Capital Management first reported a position in ANGO in Q4 2018 and held it in 5 quarters. The position peaked at $2.95M in Q3 2019. 158 funds tracked by Wall St. Rank hold ANGO as of Q1 2020.

  • Penn Capital Management reported no remaining AngioDynamics position as of Q1 2020 after selling out during the quarter.
  • Penn Capital Management sold 94,087 AngioDynamics shares in Q1 2020, an estimated $1.51M.
  • Penn Capital Management first reported a position in AngioDynamics in Q4 2018 and held it in 5 quarters.
  • Penn Capital Management's AngioDynamics position peaked at $2.95M in Q3 2019.
  • 158 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2020.

Based on Penn Capital Management's 13F filing for Q1 2020, filed 13 May 2020.